![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. Show more
LAUSANNE, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today...
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated...
LAUSANNE, Switzerland, July 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 172,400 of the...
LAUSANNE, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company is set to join the Russell 2000® Index and the broad-market Russell...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.5 | -12.8205128205 | 3.9 | 3.9823 | 3.33 | 365379 | 3.62411491 | CS |
4 | -0.12 | -3.40909090909 | 3.52 | 4.13 | 3 | 495930 | 3.6103698 | CS |
12 | -1.31 | -27.813163482 | 4.71 | 4.83 | 2.4505 | 779538 | 3.4068557 | CS |
26 | 0.11 | 3.34346504559 | 3.29 | 6.04 | 2.4505 | 731294 | 3.94565814 | CS |
52 | 2.1 | 161.538461538 | 1.3 | 6.04 | 0.359908 | 622048 | 2.92296072 | CS |
156 | -17.6 | -83.8095238095 | 21 | 32 | 0.359908 | 466004 | 5.25502296 | CS |
260 | -26.6 | -88.6666666667 | 30 | 56.5899 | 0.359908 | 407524 | 10.03781927 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions